Director, Pharmacometrics
Pubblicato il 01-10-2026 - Altro in Italia
Step into a role where science meets strategy and your expertise shapes the future of drug development. As a Director, Pharmacometrician, you'll lead high-impact modeling and simulation efforts within a dynamic Clinical Pharmacology, Modeling and Simulation (CPMS) environment. You'll guide teams, mentor pharmacometricians, and provide strategic insight to clients at key development milestones. This role also offers the opportunity to represent clients in interactions with regulatory agencies. If you thrive on collaboration and solving complex scientific challenges, this is your chance to make a meaningful impact.
About the role
This role combines scientific leadership and strategic impact, leading population PK analyses while developing innovative approaches to improve efficiency and accuracy. You will design, analyze, and interpret clinical pharmacology studies, provide strategic guidance to clients, and contribute to regulatory documents and agency interactions. In addition, you'll foster client relationships, support business development,
and stay at the forefront of PK/PD advancements to drive continuous improvement.
Your main responsibilities will include but not limited to:
Lead and conduct population PK analyses using advanced modeling tools and methodologies
Develop and implement innovative approaches to enhance the efficiency and accuracy of PK analysis
Design, analyze, and interpret clinical pharmacology studies (renal, hepatic, TQT, ADME, DDI, BE/BA, SAD, MAD, etc.) and provide guidance tooptimizepharmacokinetic sampling and dosing strategies
Provide strategic guidance to clients, owning deliverables and developing clinical pharmacology plans
Author and review PK reports and clinical pharmacology sections of regulatory documents
Represent clients in regulatory interactions and contribute to business development and relationship management
About You
If you are a driven clinical pharmacology professional with 6–10 years of experience in drug development and